📄 Redirect examination of Dr. Bruce Weir (part 1) — Monday, June 26, 1995
Address:
C:\DEPT103\CRIMINAL\1995\JUN\26\REDIRECT-EXAMINATION-OF-DR-BRU.DOC
TRIAL
▲ Day 103 of 167

Redirect examination of Dr. Bruce Weir (part 1)

Witness: Dr. Bruce Weir
Examiner: George Clarke
Called by: Prosecution • Date: Monday, June 26, 1995 • Utterances: 390
Dr. Bruce Weir, the prosecution's DNA statistics expert, acknowledged errors in his mixture frequency calculations from the prior week and presented corrected numbers for multiple samples from the Bronco, the left-hand glove, and the Bundy crime scene. Clarke used the redirect to show that while the corrected numbers were modestly lower, they conveyed the same general impression — that the mixed DNA profiles were not especially rare — and that the errors were unintentional artifacts of how his computer program handled the 1.2 DQ-Alpha allele.
1 THE COURT:

All right. Mr. Clarke. Thank you, counsel.

2 MR. CLARKE:

Thank you, your Honor.

3 THE COURT:

You may commence redirect examination.

REDIRECT EXAMINATION BY MR. CLARKE

4 MR. CLARKE:

Dr. Weir, with regard to your describing the approximate frequencies for mixtures that you just spoke about with Mr. Neufeld a few moments ago--

5 DR. WEIR:

Yes.

6 MR. CLARKE:

--what's your opinion about whether or not such frequencies should be placed on mixed samples?

7 DR. WEIR:

I think they're totally misleading. They completely ignore the fact that there is a mixture. We are trying to interpret the evidence of a matching stain in a mixture. Not to take into account that it is a mixture I think is misleading.

KEY QUOTE
8 MR. CLARKE:

Okay.

9 THE COURT:

Doctor, why don't you pull the microphone all the way to you.

10 DR. WEIR:

I'm sorry.

11 THE COURT:

Thank you.

12 MR. CLARKE:

In particular--and let's set aside for the moment the way Mr. Neufeld asked you or had you calculate frequencies for some of these mixtures. Aside from that, what about applying the frequency to mixtures at all? How do you feel about that?

13 DR. WEIR:

Well, it is useful to--we have the--the evidence is that there's a mixed stain and the profile in the mixture matches that of known people, and it may be sufficient to stop there in saying that there's a match for failure to exclude those people. But it is useful to say if this is an astonishing event or not and it gives us some sense of whether we should be surprised to see such a mixture.

14 MR. CLARKE:

Now, you've described the fact that you had previously not testified in any other case to these approximate frequencies for mixtures; is that right?

15 DR. WEIR:

That's right. Yes.

16 MR. CLARKE:

In this particular case, were you asked to calculate frequencies for the mixtures in these results?

17 MR. NEUFELD:

Objection, your Honor.

18 THE COURT:

Overruled.

19 DR. WEIR:

Yes, I was--believed I was asked late in may to do that.

20 MR. CLARKE:

Who were you asked by?

21 MR. NEUFELD:

Objection, your Honor.

22 THE COURT:

Sustained. Sustained.

23 MR. CLARKE:

Were you in fact--well, let me rephrase that. Did you in fact calculate these frequencies for these mixtures--and I'm talking about now the stains that have more than one source so that we're clear about which samples we're talking about.

24 DR. WEIR:

All right.

25 MR. CLARKE:

Were you in fact asked to calculate mixtures for those frequencies as a result of a direct order of the Court?

26 DR. WEIR:

Yes, I understand I was.

27 MR. CLARKE:

Have you been previously asked by any courts or ordered by any courts to present frequencies for mixtures in any other case you've been involved in?

28 DR. WEIR:

No. I've never been involved in a case in which there were mixed stains.

29 MR. CLARKE:

Now, I'd like to take you, Dr. Weir, if I could, to--

30 MR. CLARKE:

And, your Honor, with the Court's permission, I would like to use the glove results board for a moment. For the record, your Honor, that's exhibit 272-B.

31 THE COURT:

272-B, glove results board.

32 MR. CLARKE:

And in particular, if I can draw your attention, Dr. Weir--and I don't know if you can see it--but there is at the very top--

33 DR. WEIR:

Excuse me. May I refer to my copy? It will be a little bit easier.

34 MR. CLARKE:

Yes. You're referring to one of those smaller Xerox copies--

35 DR. WEIR:

Yes, if that's convenient.

36 MR. CLARKE:

--of the glove results chart?

37 DR. WEIR:

Yes.

38 MR. CLARKE:

In particular, at the very top is an item described on the chart as "Inside back of wrist and back below little finger." Do you see that?

39 DR. WEIR:

That's right, yes.

40 MR. CLARKE:

To your knowledge, is that the only mixture that you were asked to calculate a frequency for that came about as a result of testing by the Los Angeles Police Department?

41 DR. WEIR:

Yes. And that's indirect knowledge. I think it was you who brought that to my attention.

42 MR. CLARKE:

Yes. And when were you actually--well, were you--I'm sorry. Let me rephrase that. Were you asked by me to calculate a frequency as to that particular sample?

43 DR. WEIR:

Yes, I was.

44 MR. CLARKE:

When did I ask you to do that?

45 DR. WEIR:

I think it was Wednesday evening of last week.

46 MR. CLARKE:

Would that be the night before your initial testimony in this case?

47 DR. WEIR:

That's right. I'm not sure if it was Wednesday or Thursday. It was one of those two nights.

48 MR. CLARKE:

Is that--well, let me rephrase that. Is that the only sample that you were asked to calculate a mixture frequency for from the LAPD?

49 DR. WEIR:

Yes, it is.

50 MR. CLARKE:

Now, I would like to turn your attention to--

51 MR. CLARKE:

With the Court's permission, I would like to put up the Bronco automobile result board.

52 (Brief pause.)
53 MR. CLARKE:

Exhibit 260, your Honor.

54 THE COURT:

All right. 260, Bronco results board.

55 MR. CLARKE:

And referring you--first of all, Dr. Weir, do you have a smaller version of the Bronco results board also?

56 DR. WEIR:

Yes. I have it in front of me.

57 MR. CLARKE:

In particular, I'd like to refer your attention to item no. 31 labeled the center console. Do you see that?

58 DR. WEIR:

Yes, I do.

59 MR. CLARKE:

You have described previously that you have reported frequencies for that mixture based on the 1.2 allele being actually present; is that right?

60 DR. WEIR:

That's right.

61 MR. CLARKE:

You described both I believe last week as well as earlier today that you, when you calculate your frequencies, calculate those numbers based on the types that the analyst reports as being present.

62 DR. WEIR:

That's right, yes.

63 MR. CLARKE:

In that particular sample--and let's start with the results board--does that result in fact indicate the 1.2 is present?

64 DR. WEIR:

Yes, it does. It has--does not have the word "Possible" or any other descriptive there. It's quite clearly there just by itself.

65 MR. CLARKE:

Did you take any steps to verify the presence of that 1.2 allele by any conversation or communication with any testing analyst?

66 DR. WEIR:

Well, I noticed that it was different from other instances where the 1.2 was written with "Possible." So I checked with Gary Sims.

67 MR. NEUFELD:

Objection as to what Mr. Sims said.

68 THE COURT:

Overruled.

69 MR. CLARKE:

You may continue.

70 DR. WEIR:

I checked with Mr. Gary Sims.

71 THE COURT:

All right. He checked with Mr. Sims period. Next question.

72 MR. CLARKE:

As a result of that conversation, did you then--well, let me rephrase that a little differently. As a result of that conversation, did it verify in your mind the presence of the 1.2 allele in that sample?

73 MR. NEUFELD:

Objection. Assumes hearsay.

74 THE COURT:

Overruled.

75 DR. WEIR:

I had no doubt in my mind that Mr. Sims thought that 1.2 was there.

76 MR. NEUFELD:

Objection to what Mr. Sims thought. Strike that answer.

77 THE COURT:

That will be stricken.

78 MR. CLARKE:

What I'm actually referring you to, if I may, Dr. Weir, as a result of that conversation, did you then calculate--or actually let me rephrase that. Did it verify in your mind that your previous calculation was appropriate?

79 DR. WEIR:

Yes, it did.

80 (Discussion held off the record between the Deputy District Attorneys.)
81 MR. CLARKE:

Is it then correct that with regard to item no. 31 and the frequencies that are written off to the far right, which are for both two contributors, three contributors and four contributors, are then accurate?

82 DR. WEIR:

Well, they haven't changed since Friday. So I have in my--well, maybe I should look and see what's there.

83 MR. CLARKE:

All right. If you would in this instance.

84 DR. WEIR:

These seem to be consistent with what we said on Friday. These results haven't changed.

85 MR. CLARKE:

In other words, there was no need in your opinion to change any of the numbers on item no. 31 based on your conversation with Gary Sims as well as the data that had been presented to you before?

86 MR. NEUFELD:

Objection, your Honor. Vague as to conversation.

87 THE COURT:

Overruled.

88 DR. WEIR:

That's right.

89 MR. CLARKE:

Now, I'd like to turn your attention, Dr. Weir, if I could to item no. 29. Do you recall Mr. Neufeld asking you some questions towards the end or very end of his cross-examination?

90 DR. WEIR:

Yes, I recall that.

91 MR. CLARKE:

And in particular, do you recall questions he asked you about whether or not the 1.2 allele in the sample no. 29--and I'm referring to the DQ-Alpha results--may or may not have been present? Do you recall that question?

92 DR. WEIR:

Yes. He was asking me that.

93 MR. CLARKE:

Now, with regard to that sample--and let's refer to the chart itself--there are actually results on item no. 29 at the DQ-Alpha marker from two different laboratories; is that right?

94 DR. WEIR:

That's right. Both DOJ and Cellmark have results.

95 MR. CLARKE:

Let's focus initially on the Department of Justice's results. That's the upper most of the two laboratories that are listed to the right of item 29?

96 DR. WEIR:

That's right.

97 MR. CLARKE:

Those results, do they make any statement about whether or not the 1.2 allele is present?

98 DR. WEIR:

No. It's just listed without any descriptor.

99 MR. CLARKE:

There's no language like "Possible"?

100 DR. WEIR:

No.

101 MR. CLARKE:

Referring you to Cellmark's results as well on that same item, is there any qualifier about the presence of the 1.2 allele for item no. 29?

102 DR. WEIR:

No, there's not.

103 MR. CLARKE:

I'd like you to assume hypothetically that the analyst testified in this case that with regard to item 29, the 1.2 allele is present based on their interpretation of the data. Would your frequencies under that hypothetical that you have listed off to the right--

104 MR. CLARKE:

Well, let me rephrase that if I may, your Honor. I'm sorry.

105 MR. CLARKE:

Have you made a recalculation of a portion of item no. 29 as far as the frequencies themselves?

106 DR. WEIR:

A small portion of them, I have, yes.

107 MR. CLARKE:

Okay. What does that relate to?

108 DR. WEIR:

That's a different issue. It's--are we allowed to multiply together all the numbers in the profile, and there's a hint of some dependence in one of the FBI's databases, their black database. So for any calculation involving black database, I--oh, I'm answering too much. That refers to the polymarker. Excuse me. The DQ-Alpha I did not change. I'm sorry.

109 MR. CLARKE:

Okay. That's what I'd like to focus your attention on--

110 DR. WEIR:

Excuse me.

111 MR. CLARKE:

--is--at the moment, the DQ-Alpha results.

112 DR. WEIR:

Thank you. So I have not changed the DQ-Alpha.

113 MR. CLARKE:

In your view, as a result--and again, assuming hypothetically that both analysts testified to the presence of the 1.2 allele, is there any reason that you should assume it is not present?

114 DR. WEIR:

No.

115 MR. CLARKE:

Now, your Honor, what I'm going to ask the witness to do is, with respect to certain calculations, we have prepared numbers in accordance with the recalculations already described by the witness, and I have magnetic boards that I would like to use with numbers already written on them.

116 THE COURT:

Proceed. Have you shown these to Mr. Neufeld?

117 MR. CLARKE:

No, I have not.

118 (Discussion held off the record between the Deputy District Attorney and Defense counsel.)
119 (Brief pause.)
120 THE COURT:

All right. Mr. Clarke, why don't you start with the ones Mr. Neufeld already has had a chance to look at.

121 MR. CLARKE:

First of all, with a number of these mixtures that you described earlier today, have you had an opportunity to recalculate them over the weekend?

122 DR. WEIR:

Yes, I have.

123 MR. CLARKE:

First of all, with regard to--and let's start initially with items 303, 304 and 305 that are from the center console of the Bronco.

124 DR. WEIR:

Fine.

125 MR. CLARKE:

Those all actually in your initial or original testimony about frequencies under these various possible combinations, those numbers were the same for all three of those items; is that right?

126 DR. WEIR:

That's right and they'll remain so. The profiles are the same.

127 MR. CLARKE:

As far as the calculations you described in your testimony last week, did you commit an error in making those calculations?

128 DR. WEIR:

Yes, I did.

129 MR. CLARKE:

Do you know how to calculate them properly?

130 DR. WEIR:

Yes, I do. That's what makes me so angry with myself.

KEY QUOTE
131 MR. CLARKE:

Is it the case that what you left out was the assumption that the 1.2 allele for these three samples might not be there?

132 DR. WEIR:

As it turned out, that was--I thought I was doing it correctly, but the way I had written--my computer program did not fill that in properly. I thought it had and it hadn't.

133 MR. CLARKE:

The effect of assuming that the 1.2 allele may not be there, how did that impact your calculations? If you can describe that in a simple fashion.

134 DR. WEIR:

Well, the profiles all appeared to be more common than I had reported on Friday.

135 MR. CLARKE:

Did you leave out this possibility on purpose?

136 DR. WEIR:

No, sir. I left it out for all the profiles that involved the 1.3 and the 4. Every time I should have made this accommodation, I failed to.

137 MR. CLARKE:

Did you try to hide it when it was pointed out to you?

138 DR. WEIR:

It was so obvious, there was no way. In fact, I--I've pointed out now that I did additional items.

KEY QUOTE
139 MR. CLARKE:

If outside of court Mr. Neufeld had pointed it out to you, that it was missing, would you have corrected it then?

140 MR. NEUFELD:

Objection. Irrelevant.

141 THE COURT:

Sustained. Calls for speculation.

142 MR. CLARKE:

Would you have included it if anyone had pointed out to you that it was missing?

143 MR. NEUFELD:

Objection. Irrelevant.

144 THE COURT:

Sustained. Speculation.

145 MR. CLARKE:

Would you have included it if you yourself had discovered it missing in reading your report?

146 MR. NEUFELD:

Objection. Again, it's speculative.

147 THE COURT:

Overruled.

148 DR. WEIR:

Absolutely. Yes.

149 MR. CLARKE:

Have you since last week made that calculation or those calculations for these three samples, 303, 304 and 305?

150 DR. WEIR:

Yes, I have.

151 MR. CLARKE:

Have you also made those calculations for a few other samples that the same occurrence happened in?

152 DR. WEIR:

That's right. I have.

153 MR. CLARKE:

Now, referring you, if I can, to what appear to be three magnetic covers labeled 303, 304 and 305. Those appear to have numbers written in the same manner as what's currently on the Bronco results chart for the possibility of two contributors, three contributors and four contributors; is that right?

154 DR. WEIR:

That's right. Yes.

155 MR. CLARKE:

And do those three magnetic covers for items 303 through 305, do they appear to have the corrected numbers accounting for the possibility that the 1.2 allele was not present?

156 DR. WEIR:

Yes, they do.

157 MR. CLARKE:

All right.

158 MR. CLARKE:

With the Court's permission then, I'd like to apply those to the board bearing in mind they can be removed because they're magnetic.

159 THE COURT:

Proceed.

160 MR. CLARKE:

Now, Dr. Weir, what I'm going to ask you to do is, as far as both the old and the new calculations for--and let's just take 303. Do you have each of those numbers in front of you so that you don't have to try to read the board from an angle?

161 DR. WEIR:

I have one. Let me get the other one.

162 (Brief pause.)
163 DR. WEIR:

Right.

164 MR. CLARKE:

Now, the original numbers reported--and I'll use 303--for the assumption of two contributors in the mixture was 1 in 1,400 as the most common; is that right?

165 DR. WEIR:

That's right.

166 MR. CLARKE:

And the new approximate frequency is 1 in 570; is that right?

167 DR. WEIR:

That's right.

168 MR. CLARKE:

How would you characterize that difference between those two?

169 DR. WEIR:

Well, they're different numbers obviously. One's about little over twice the size of the other one. They both convey the impression that the profile is not especially rare. It's--I don't know if you have to have a particular good--I don't have a particularly good word to describe it, but it has the frequency in either the hundreds or the low thousands, whichever way we go.

170 MR. CLARKE:

Okay. The least common for two contributors is 1 in 18,000; is that right? And I'm referring to the frequencies you provided in Court last week.

171 DR. WEIR:

The old figures are 18,000, yes.

172 MR. CLARKE:

And is the new figure at the upper range, that is the least common, approximately 1 in 10,000?

173 DR. WEIR:

That's right, yes.

174 MR. CLARKE:

Would your comments about the difference between 18,000 and 10,000 be consistent with what you just described about the difference at the most common number?

175 DR. WEIR:

Yes. Yes.

176 MR. CLARKE:

Now, I'd like to turn your attention, if I could, to three contributors.

177 DR. WEIR:

All right.

178 MR. CLARKE:

And when you comment about 303, your comments, do they not, apply equally to 304 and 305 as well?

179 DR. WEIR:

That's right. It's the same profile and the same numbers are going to apply.

180 MR. CLARKE:

Now, first of all, in terms of the actual results of the DNA tests themselves, there are three individuals in this case who are not excluded from the actual tests themselves on 303, 304 and 305; is that right?

181 DR. WEIR:

That's right. Yes.

182 MR. CLARKE:

In other words, Mr. Simpson is not excluded?

183 DR. WEIR:

Right.

184 MR. CLARKE:

Mr. Goldman is not excluded?

185 DR. WEIR:

Right.

186 MR. CLARKE:

And Nicole Brown is not excluded?

187 DR. WEIR:

Right.

188 MR. CLARKE:

The original frequencies that you reported for the assumption of three contributors last week, the more common number or most common was about 1 in 450; is that right?

189 DR. WEIR:

That's right. Yes.

190 MR. CLARKE:

You have recalculated, and that new number, instead of 1 in 450, is approximately what for three contributors?

191 DR. WEIR:

It's 1 in 320.

192 MR. CLARKE:

How would you characterize the difference between 450 and 320?

193 MR. NEUFELD:

Objection, your Honor. I would ask that if he do it mathematically, that I would not allow him to give opinions because the frequencies speak for themselves.

194 THE COURT:

Overruled.

195 DR. WEIR:

Well, the numbers are different. They differ by 150. That's less than a factor of two. I don't think that--I think both the numbers are conveying the same sense of the frequency of this mixture of three genotypes.

196 MR. CLARKE:

The original number--and we'll look now at the upper end, that is the least common frequency--

197 DR. WEIR:

All right.

198 MR. CLARKE:

--for three contributors again, appears to read 1 in 29,000 from last week; is that right?

199 DR. WEIR:

That's right.

200 MR. CLARKE:

The new figure is 1 in 25,000; is that right?

201 DR. WEIR:

That's right.

202 MR. CLARKE:

Again, how would you characterize the differences between 29,000 and 25,000?

203 MR. NEUFELD:

Again, your Honor, objection. Beyond his expertise.

204 THE COURT:

Overruled.

205 DR. WEIR:

It's difficult to say that they would give us a different impression. They are both saying the same thing. This mixture would occur with the frequency in the thousands.

206 MR. CLARKE:

And then lastly, on the assumption of four contributors, the range--and perhaps we can do this a little quicker--the range that you provided us last week for the assumption again of four persons contributing to that mixture was between approximately 1 in 49 to 1 in 69,000; is that right?

207 DR. WEIR:

Right.

208 MR. CLARKE:

And the new figures provided today are between 1 in 41 to 1 in 65,000; is that right?

209 DR. WEIR:

That's right.

210 MR. CLARKE:

Would your comments about the differences between your original numbers and the numbers today that you described for two and three contributors be consistent with four also?

211 DR. WEIR:

Yes.

212 MR. CLARKE:

Now, while we're on the results from the Bronco, if we could, have you also prepared a magnetic cover reflecting what should be or what are the approximate frequencies for two, three and four contributors for the steering wheel, item no. 29?

213 DR. WEIR:

Yes, I have.

214 MR. CLARKE:

And showing you a new magnetic cover, would you take a moment to look at those and tell us if those are in fact accurate estimates?

215 DR. WEIR:

Yes. These are the numbers I've calculated.

216 MR. CLARKE:

And as far as the original number for two contributors, that was from 1 in 60 to 1 in 11,000; is that right?

217 DR. WEIR:

That's right.

218 MR. CLARKE:

And the proper estimates would be from approximately 1 in 26 to 1 in 11,000?

219 DR. WEIR:

Right.

220 MR. CLARKE:

As far as assuming three contributors, the original estimate was 1 in 9 to 1 in 3500?

221 DR. WEIR:

Right.

222 MR. CLARKE:

And the new one is 1 in 2 to 1 in 3500?

223 DR. WEIR:

Right.

224 MR. CLARKE:

And then lastly, the old or former estimate was 1 in 1 to 1 in 3,000, and now it is 1 in 1 to 1 in 1300 approximately; is that right?

225 DR. WEIR:

Right.

226 MR. CLARKE:

And, your Honor, with the Court's permission, I'm going to place the 29 cover--

227 THE COURT:

Yes. Thank you.

228 MR. CLARKE:

--on the board.

229 MR. CLARKE:

As far as these estimates, Dr. Weir, that you provided last week and in some cases provided additional numbers for those samples this week, do those apply only to the mixed samples in this case?

230 DR. WEIR:

Oh, yes. These changes were only for the mixtures.

231 MR. CLARKE:

So in other words, your comments today about different numbers from the same item number have nothing to do with the estimates calculated by the laboratories for stains from one source?

232 DR. WEIR:

That's correct.

233 MR. CLARKE:

Now, I'm going to return to the glove board, if I may again, your Honor.

234 THE COURT:

Yes.

235 (Discussion held off the record between the Deputy District Attorney and Defense counsel.)
236 MR. CLARKE:

And referring you, if I can, Dr. Weir, to that portion of the glove labeled area G10, do you recall that?

237 DR. WEIR:

All right. Yes.

238 MR. CLARKE:

As far as your calculations last week, was this another example where you did not consider the possibility that the 1.2 allele on that sample may not be present?

239 DR. WEIR:

That's right. Yes.

240 MR. CLARKE:

Did you perform a recalculation similarly to that that you did with items 303, 304, 305?

241 DR. WEIR:

I did.

242 MR. CLARKE:

Showing you what's been labeled G10--

243 DR. WEIR:

All right.

244 MR. CLARKE:

--and what appear to be frequencies or estimates for either two contributors or three contributors, do those estimates reflect the calculations you've performed over the weekend?

245 DR. WEIR:

Yes, they do.

246 MR. CLARKE:

Now, the original numbers on 310--I'm sorry--area G10 on People's exhibit 272-B were from 1 in 3900 to 1 in 19,000?

247 DR. WEIR:

That's right.

248 MR. CLARKE:

Assuming two contributors?

249 DR. WEIR:

Yes. Uh-huh.

250 MR. CLARKE:

And the new numbers are 1 in 1600 to 1 in 11,000; is that right?

251 DR. WEIR:

That's right.

252 MR. CLARKE:

Assuming three contributors, the most common number went from 1 in 4600 last week to 1 in 3200 today?

253 DR. WEIR:

That's right.

254 MR. CLARKE:

And as to the rarest frequency, initially, it was 1--approximately 1 in 71,000, which is now approximately 1 in 63,000?

255 DR. WEIR:

That's right.

256 MR. CLARKE:

Can you describe for us--or how would you characterize those differences again?

257 DR. WEIR:

Well, they're real. They're obviously different numbers. I don't think how--I don't think we get a different impression of their frequencies. They both have--both tell us the frequencies are in the hundreds to thousands.

258 MR. CLARKE:

All right, your Honor. I'm going to place the G10 marker on 272-B.

259 THE COURT:

Yes.

260 MR. CLARKE:

Now, turning, if I can, to the glove. And I'm referring back to the first sample, that tested by the Los Angeles Police Department. In other words, what's listed as the first actual item on this chart. Do you understand which one I'm referring to?

261 DR. WEIR:

Yes. It doesn't have an item number, but it's the first row on the chart.

262 MR. CLARKE:

In other words, we can't refer to it as G1, G2 or G anything.

263 DR. WEIR:

That's right.

264 MR. CLARKE:

It's simply the first listed item for LA item no. 9.

265 DR. WEIR:

That's right.

266 MR. CLARKE:

Did you also calculate frequencies for that particular sample as well?

267 DR. WEIR:

I did.

268 MR. CLARKE:

And showing you what's listed as another cover--rather on which is listed frequencies for two or three contributors, do those appear to be accurate?

269 DR. WEIR:

Yes, they do.

270 MR. CLARKE:

Perhaps you can tell us--if I just ask you to describe, can you tell us the difference between those numbers and what is currently listed on the board from your testimony last week?

271 DR. WEIR:

Why don't I just read from the board? 1 in 30 to 1 in 190. Do I give the new figure?

272 MR. CLARKE:

Yes.

273 DR. WEIR:

So the 1 in 30 becomes a 14 and the 1 in 90 becomes a 60. The three contributors, the 1 in 6 becomes 1 in 4. The 1 in 90 becomes 1 in 180.

274 MR. CLARKE:

All right. With the Court's permission, I'll apply this cover.

275 THE COURT:

Yes.

276 MR. CLARKE:

And now if we can deal with one in a set of three again, with regard to G1, G2 and G4, those three samples contain the same set of types as far as the PCR results; is that right?

277 DR. WEIR:

Yes. They have the same profile. So they'll have the same numbers.

278 MR. CLARKE:

So like 303, 304 and 305, can we deal with them all as one?

279 DR. WEIR:

Yes, sir.

280 MR. CLARKE:

Okay. Showing you covers for G1, G2 and G4, could you take a moment to look at those three.

281 (Witness complies.)
282 DR. WEIR:

Yes. They're all accurate.

283 MR. CLARKE:

Now, these recalculations were--

284 DR. WEIR:

Excuse me. That's G1, G2 and G4?

285 MR. CLARKE:

Yes.

286 DR. WEIR:

That's right. Yes.

287 MR. CLARKE:

These recalculations were made as a result of your discovery of what that impacted the frequencies or the estimates you provided last week?

288 DR. WEIR:

This is the same phenomena. This is the failure to account properly for the DQ-Alpha type.

289 MR. CLARKE:

All right. Then let's go right to and let's just use G1 as our example.

290 DR. WEIR:

All right.

291 MR. CLARKE:

Can you describe for us--and let's turn to the original estimates for these mixtures on G1 or this mixture. Your original estimate for two contributors was approximately 1 in 600 to 1 in 11,000; is that right?

292 DR. WEIR:

Right.

293 MR. CLARKE:

And is it correct that for that same assumption of two contributors, the estimate is 1 in 240 to 1 in 6300?

294 DR. WEIR:

That's right.

295 MR. CLARKE:

As far as three contributors, your initial estimate was approximately 1 in 400 to 1 in 36,000?

296 DR. WEIR:

Yes.

297 MR. CLARKE:

And would the new estimate for three contributors be 1 in 280 to 1 in 32,000?

298 DR. WEIR:

That's right.

299 MR. CLARKE:

As far as the differences between these numbers and those described by you last week, would your comments that you made earlier be the same or apply here as well?

300 DR. WEIR:

Yes, they would.

301 MR. CLARKE:

And, your Honor, with the Court's permission, I'm going to put the cover on each of G1, G2 and G4, but only the PCR portion.

302 THE COURT:

Yes.

303 MR. CLARKE:

Dr. Weir, incidentally, as far as these magnetic covers, they can be removed to see what's underneath them; is that right?

304 DR. WEIR:

I understand so, yes.

305 MR. CLARKE:

Okay. And in fact, it does appear that I'm able to remove them and put them back. Turning your attention now to G3 and G9, do those two samples also go together as far as calculating these approximate frequencies for PCR mixtures as to those samples?

306

DR. WEIR: Yes, they do. (Discussion held off the record between the Deputy District Attorneys.)

307 MR. CLARKE:

Let's start with G3.

308 DR. WEIR:

All right.

309 MR. CLARKE:

Your initial calculation on G3 was approximately 1 in 3900 to 1 in 22,000 for two contributors?

310 DR. WEIR:

Yes.

311 MR. CLARKE:

I'm sorry.

312 DR. WEIR:

Excuse me. I just said yes. Uh-huh.

313 MR. CLARKE:

And the frequencies that you have provided today, instead of 1 in 3900, the more common would be or most common, approximately 1 in 1600?

314 DR. WEIR:

That's right.

315 MR. CLARKE:

And as far as the initial calculation for the high end, assuming two contributors--

316 DR. WEIR:

Right.

317 MR. CLARKE:

--was originally 1 in 22,000?

318 DR. WEIR:

Right.

319 MR. CLARKE:

And is that now approximately 1 in 12,000?

320 DR. WEIR:

Yes.

321 MR. CLARKE:

Turning to three contributors, that range as far as G3 again was originally from 9,000 to 150,000?

322 DR. WEIR:

Yes.

323 MR. CLARKE:

And now that range is approximately 6500 to 229,000?

324 DR. WEIR:

Yes.

325 MR. CLARKE:

With the Court's permission, I'm going to cover again the PCR portion of G3.

326 THE COURT:

Thank you.

327 MR. CLARKE:

And lastly, as to the glove, Dr. Weir, showing you what's labeled G9, these are supposed to be the same numbers as G3; is that right?

328 DR. WEIR:

They should be, yes.

329 MR. CLARKE:

One of those numbers looks like it's actually been smudged; is that right?

330 DR. WEIR:

It does.

331 MR. CLARKE:

Can you tell us what that number should be?

332 DR. WEIR:

The number should be the same as the G3, 1 in 229,000.

333 (Discussion held off the record between the Deputy District Attorneys.)
334 MR. CLARKE:

Perhaps I can take a red pen and make that clearer, but that--

335 DR. WEIR:

229,000.

336 MR. CLARKE:

So that with regard to G9, these would be the same ranges as G3; is that right?

337 DR. WEIR:

That's right. That should be the same, yes.

338 MR. CLARKE:

Your Honor, I would like to put this cover on G9 as well.

339 THE COURT:

Yes.

340 MR. CLARKE:

Now, using this example, before I put the cover on, Dr. Weir, it appears, for instance, that with regard to the assumption of three contributors, the calculations that you've made and described just now in court, that the upper range is even rarer than the original range that you provided for three contributors on this sample; is that right?

341 DR. WEIR:

Yes. It's just more difficult to arrive at that--that range. It's a little difficult to make general statements about how the numbers will come out, but it's a rare event when I do it properly.

342 MR. CLARKE:

So, in other words, it's not necessarily the case at all that when you make your calculations based on the assumption the 1.2 allele may not be present, that in fact the range may show us that it's something that's even a rarer event?

343 MR. NEUFELD:

Objection. Misstates the evidence, only the upper range.

344 THE COURT:

Sustained. Rephrase the question.

345 MR. CLARKE:

Is it the case, Dr. Weir, that when you perform your recalculations, at least one of the ends of the range may be rarer than you calculated it last week?

346 DR. WEIR:

Yes. Yes.

347 (Discussion held off the record between the Deputy District Attorneys.)
348 MR. CLARKE:

And lastly, your Honor, I'd like to refer to--as far as these mixtures, to the Bundy results board.

349 THE COURT:

Yes. Is this 78?

350 MR. CLARKE:

Yes.

351 (Brief pause.)
352 MR. CLARKE:

Dr. Weir, referring you to item no. 78, and in particular, the PCR portion of the frequencies off to the right of that particular item?

353 DR. WEIR:

All right.

354 MR. CLARKE:

That's the drop from Ronald Goldman's boot; is that right?

355 DR. WEIR:

Right.

356 MR. CLARKE:

Did you also recalculate the possible range or estimates for the range of the characteristics from that particular item based on the PCR markers only?

357 DR. WEIR:

I did.

358 MR. CLARKE:

And have you calculated those and are they accurately reflected on another magnetic cover labeled item no. 78, PCR?

359 DR. WEIR:

Yes. This is accurate.

360 MR. CLARKE:

Could you tell us the original range and that reflected on the magnetic cover as well?

361 DR. WEIR:

Let me read from the board. So 78, the--we had the hundred--the 1--looks like--your writing is worse than mine, Mr. Clarke.

362 MR. CLARKE:

It does appear bad.

363 DR. WEIR:

Looks like 1 in 285 to 120,000. That becomes 1 in 110 to 1 in 16,000. So three contributors, 1 in 60 to 1 in 490,000 becomes 1 in 42 to 1 in 44,000.

364 MR. CLARKE:

Could you verify in your calculations--can you tell us whether the old number for two contributors was 1 in 285?

365 DR. WEIR:

You'd just have to give me a minute. That sounds right. I need to check. Item 78 was--yes, the lower end was 1 in 285. 285.

366 MR. CLARKE:

So it's 285?

367 DR. WEIR:

Yes.

368 MR. CLARKE:

And the new number is what?

369 DR. WEIR:

110.

370 MR. CLARKE:

And as far as the three contributors, what would be the most common? In other words, if you could tell us the old and the new number as far as three contributors in the most common end of the range.

371 DR. WEIR:

The old number was 1 in 61 to 1 in 490,000 and now it's 1 in 42 to 1 in 44,000.

372 MR. CLARKE:

All right. And, your Honor, I would like to put that cover on the board also.

373 MR. CLARKE:

Dr. Weir, could you describe for us approximately how many calculations you've had to do in this case? And I'm referring to--and I'm having you, if you would, set aside recalculations. Just the calculations you did initially?

374 DR. WEIR:

Just on the mixtures?

375 MR. CLARKE:

Everything.

376 DR. WEIR:

Everything. I don't think so. There are many, many items of evidence on these charts. Many of them have multiple loci, and I've done a lot of things with them. So certainly several hundred calculations.

377 MR. CLARKE:

As far as these frequencies that you have recalculated, those involve mixtures alone; is that right?

378 DR. WEIR:

That's right.

379 MR. CLARKE:

In terms of these frequencies on the mixtures and on the current board, the Bundy board, item no. 78 appears to be the only mixture; is that right?

380 DR. WEIR:

I think that's right, yes.

381 MR. CLARKE:

As far as those frequencies are concerned, do they take into account in any manner any of the known types of either Mr. Simpson, Nicole Brown or Ronald Goldman?

382 DR. WEIR:

No, they don't. None of the calculations I do take into account the included people.

KEY QUOTE
383 MR. CLARKE:

What does that mean? Can you describe what you mean by that?

384 DR. WEIR:

Well, we have--we have an item of evidence and a DNA profile which matches some known people. And we set that aside. We say there's a match. Well, I mean, the investigation proceeds because there is a match. Having the match--once the match has been declared, that is set aside for all these calculations, and then we say where we have this profile, how likely is that profile if there were unknown contributors, people we don't know anything about. So all these numbers refer to the unknown people.

385 MR. CLARKE:

So, in other words, your frequencies for all of these mixtures are calculated without regard to whoever they may or may not be consistent with in this case?

386 DR. WEIR:

That's right. Yes.

387 MR. CLARKE:

As far as your recalculation--well, I'm sorry. Let me rephrase that. These calculations, not taking into account any of these known people, is that different in any way from the calculations done for a single source stain; for instance, anything but 78 on this Bundy results board?

388 DR. WEIR:

No. The single stains are just the same. If there's a single stain, it has a profile which matches a single person. That person is set aside, the calculation is done to get the chance of getting that profile typed if there was an unknown contributor.

389 MR. CLARKE:

And again, going back to the mixtures then, for example, on just the PCR results alone on item no. 78, when you say that if there are two contributors, the frequency is approximately 110 to 16,000, that's just looking at two contributors at random on the entire planet?

390 DR. WEIR:

That's right.

Temperature

procedural

Key Quotes (5)

Dr. Bruce Weir
I think they're totally misleading. They completely ignore the fact that there is a mixture.
Weir explains why applying single-source frequency statistics to mixed DNA samples is scientifically inappropriate, defending his approach on cross while conceding error in his specific calculations.
Dr. Bruce Weir
That's what makes me so angry with myself.
Candid admission that he knew how to calculate the frequencies properly but made a programming error — humanizes the expert and undercuts the defense narrative that the errors were deliberate or systemic.
Dr. Bruce Weir
It was so obvious, there was no way. In fact, I've pointed out now that I did additional items.
Weir proactively volunteered that he found additional errors beyond what Neufeld had flagged, bolstering his credibility as a witness acting in good faith.
Dr. Bruce Weir
your writing is worse than mine, Mr. Clarke.
Rare light moment in an otherwise technical proceeding, briefly breaking the density of the numerical testimony.
Dr. Bruce Weir
None of the calculations I do take into account the included people.
Clarifies the statistical methodology — the frequencies describe how common a profile would be among unknown contributors, not a probability that Simpson or the victims are the source.

Evidence (3)

People's 272-B
Glove results board showing PCR/DQ-Alpha DNA test results for multiple areas of the left-hand glove
discussed; corrected magnetic number covers applied to areas G1, G2, G4, G3, G9, G10, and the LAPD-tested sample
People's 260
Bronco automobile results board showing DNA test results for multiple interior locations
discussed; corrected magnetic number covers applied to items 303, 304, 305 (center console) and item 29 (steering wheel)
Informal
Bundy results board, item no. 78 — blood drop from Ronald Goldman's boot at the crime scene
discussed; corrected magnetic cover applied showing revised PCR mixture frequency estimates

Notable Exchanges (3)

George ClarkeDr. Bruce Weir
Clarke walks Weir through each corrected mixture frequency sample-by-sample, replacing old numbers with magnetic covers. Weir consistently characterizes the differences as real but not impression-changing — both old and new numbers place the profiles in the 'hundreds to thousands' range.
strategic
Peter NeufeldLance A. ItoGeorge Clarke
Neufeld objected to Clarke asking whether Weir would have corrected the error had Neufeld (or anyone else) pointed it out outside court. Ito sustained on relevance and speculation grounds, cutting off Clarke's attempt to rehabilitate Weir's good-faith intent through that line of questioning.
procedural
Dr. Bruce WeirLance A. Ito
When Weir began explaining the polymarker recalculation unprompted during a question about DQ-Alpha, Ito let him self-correct and refocus without interruption.
routine

Light Moments (1)

Dr. Bruce Weir
Dr. Weir, struggling to read Clarke's handwriting on a magnetic cover, remarked: 'your writing is worse than mine, Mr. Clarke.' Clarke responded 'It does appear bad.'

Credibility Attacks (1)

⚔ Dr. Bruce Weir
prior inconsistent calculation / error on direct
Clarke's redirect was itself structured around repairing damage from Neufeld's cross, where Weir's mixture frequency calculations were shown to be erroneous. Clarke rehabilitated Weir by having him acknowledge the errors openly, explain their mechanical cause (a computer program that failed to account for the possibility that the 1.2 DQ-Alpha allele was absent), and demonstrate that the corrected figures conveyed the same forensic impression as the originals.

Witness Demeanor

(Witness self-corrects mid-answer when he realizes he is describing polymarker recalculations rather than DQ-Alpha recalculations)
(Brief pause while witness retrieves smaller copies of results boards)
(Witness complies — reviews covers for G1, G2, G4)

Objections

11 objections (4 sustained, 6 overruled)
Proceeding 6559 • 390 utterances • Prosecution witness
Criminal Trial
Department 103
⚖️ Start
📂 JUN 26, 1995 📄 Redirect examination of Dr. Br
JUN 26, 1995 KRT DvH TD